Study reveals variability in polygenic risk scores for predicting heart disease

Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the genome to estimate a person’s risk of developing certain diseases, such as coronary artery disease (CAD).

Pediatric Associates Selects Innovaccer’s AI Platform to Enhance Quality of Care for 1.5 Million Patients

What You Should Know: – Pediatrics Associates, the leading private pediatric primary care group in the US, has partnered with Innovaccer Inc., a leader in

June 7, 2024

Clearmind Secures New Patent for Psychedelic Therapy

The TDR Three Key Takeaways for Clearmind: Clearmind Medicine’s innovative therapy gets patent approval in China. The company’s IP portfolio now includes 27 granted patents

March 20, 2024

Biopharma firm Zetagen raises $9.79m in Series B financing round

In preclinical research, Zetagen’s ZetaMAST showed potential to stop lesion growth. Credit: Zetagen. Clinical-stage biopharma firm Zetagen Therapeutics has raised $9.79m in a Series B

August 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.